News & Views
Altacor Strengthens Commercial Capability
Jul 31 2013
European pharmaceutical company Norgine is to promote Cambridge-based Altacor’s Dry Eye product Clinitas® in the UK through its primary care sales teams.
Clinitas is a preservative free eyedrop for moderate Dry Eye that is prescribed by hospital-based ophthalmologists and primary care professionals and the agreement will help to raise product awareness in the part of medical community that is responsible for the continuity of patient care via follow-on prescribing from hospital recommendation.
Peter Stein, Chairman of Norgine said: “We are pleased to initiate this collaboration with Altacor as a first step in what may become a broader partnering.”
Dr Fran Crawford, CEO of Altacor added, “We are particularly excited to be working with Norgine in such a creative approach to sales and marketing of specialty ophthalmology products. This deal will help grow sales of our Clinitas products for Dry Eye and provides us with a much stronger overall commercial platform in the UK. Our relationship with Norgine is important and we hope it will allow Altacor to identify further strategic opportunities to leverage Norgine’s pan-European commercial infrastructure and establish Altacor as a leading European specialty ophthalmology company.”
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan